HDGF and neoplasm: We demonstrated that mir-129-5p is inducible by epigenetic drugs (i.e. HDACi) and exhibits distinct tumor-suppressive functions by downregulating HDGF. Therefore, our data suggest that miR-129-5p may be suitable for therapeutic application and is a promising candidate for a miRNA replacement therapy in advanced HCC.